Back in 1997, when mitoxantrone + prednisone became the first form of chemotherapy ever to be approved for the treatment of prostate cancer, the Southwest Oncology Group (SWOG) initiated a trial generally referred to as S9921 — and some of the results of this trial were presented at the annual meetings of the AUA and [...]
Filed under: Management, Treatment | Tagged: ADT, androgen deprivation therapy, combined, survival | 1 Comment »
Search for new and
ongoing trials on the
CTAG PCa web site
